Anonymous and Pseudonymous Health Data: European and U.S. Perspectives

Event: International Privacy & Security Forum, Washington, D.C., April 3–5, 2019

Different legal orders have taken varying approaches to regulating the collection, analysis and sharing of personally identifiable health data and to defining requirements for rendering health data anonymous. This topic is of great importance for hospitals, pharmaceutical companies, and medical device manufacturers. It is also raised by developments in the "internet of medical things".  This session of the International Privacy & Security Forum 2019 discussed how organizations can develop and deploy innovative products and services, while complying with sometimes competing demands for the use of anonymous or pseudonymous health data in EU, Swiss, and U.S. law.

Kategorien: Data & Privacy, Publikationen & Präsentationen